BBIO
#781
BridgeBio Pharma, Inc. - Common Stock
63.3 0 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.73%
Variación mensual
-12.40%
Variación en los últimos 6 meses
-18.85%
Cambio anual
+11.05%
Cierres anteriores
65.7 5
Open
66.0 5
Mínimo
62.9 4
Máximo
66.0 5
Financials
- Market Capitalization 12.37 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-20.24
Relación precio/flujo de caja
29.18
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 775 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 109.62 USD | -1.31% | -1.79% | +1.89% | +64.10% | 12.44 B USD | ||
| 780 |  SMMT Summit Therapeutics Inc. - Common Stock | 15.52 USD | -9.40% | -9.24% | -14.54% | -21.85% | 12.38 B USD | ||
| 823 |  TECH Bio-Techne Corp - Common Stock | 72.48 USD | -0.11% | +0.07% | +0.28% | +20.84% | 11.37 B USD | ||
| 867 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.38 USD | -1.82% | -3.07% | -17.33% | +3.90% | 10.53 B USD |